Issue: January 2013
December 10, 2012
1 min read
Save

Data reveal potential diagnostic hallmark of HPeV3

Issue: January 2013
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Because of the potential for serious complications associated with human parechovirus type 3, an accurate diagnosis is key. Recently published findings indicate that one diagnostic marker for this illness may be a rash on the hands and soles.

Perspective from José R. Romero, MD

Akihiko Saitoh, MD, PhD, of the department of pediatrics at Niigata University Graduate School of Medical and Dental Sciences in Japan, and colleagues reported the results of a retrospective analysis, in which they looked at data on 15 neonates with human parechovirus type 3 (HPeV3). The neonates were seen at the largest pediatric hospital in Japan between November 2010 and September 2011.

 

Akihiko Saitoh

The researchers said all of the children in the study developed a rash, about 3 days after developing a fever, which was the most common presentation of illness.

“The most striking finding was that 80% of patients developed a distinctive palmar-plantar erythematous rash, which disappeared after a median of 3 days,” the researchers said.

A rash is also typically seen with Kawasaki disease; however, Saitoh and colleagues said there are some important differences between these patients and those with Kawasaki disease.

“None of the present patients had other typical signs of [Kawasaki disease], which include conjunctival injection, changes in the mucosa of oropharynx, cervical lymphadenopathy, and elevation of inflammatory makers ([white blood cell] count and [C-reactive protein]),” the researchers wrote.

Akihiko Saitoh, MD, PhD, can be reached at 1-757 Asahimachi-dori Niigata, 951-8510 Japan; email: asaitoh@med.niigata-u.ac.jp.

Disclosure: The researchers report no relevant financial disclosures.